# US 11,542,281 B2 · Process for the steroselective preparation of chiral 2- [(hetero)arylalkylsulfanyl] pyrimidines and products obtainable therefrom

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 11,542,281 B2
- Document ID: US11542281B2
- Status: Granted
- Kind: B2
- Application number: 17/055,172
- Filed: 2019-05-15
- Published: 2021-06-24
- Granted: 2023-01-03
- Earliest claimed: 2018-05-15
- Assignees: Kancera AB
- Applicants: Kancera AB
- Inventors: Jan Vågberg; Styrbjörn Byström
- Web page: https://patentgrep.com/patent/US11542281B2

## CPC

- C07D 513/04: Ortho-condensed systems
- C07D 239/56: One oxygen atom and one sulfur atom
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Described herein is a process for the preparation of a compound of Formula I, wherein R1 and R2 each have the meanings provided in the description. Also described is a process for the preparation of pharmaceutically-active compounds including the process for the preparation of compounds of Formula I.

## Claims

### Claim 1

A process for the preparation of a compound of formula I,
or a salt thereof, wherein
R1 represents aryl or pyridyl optionally substituted with one or more groups selected from halo, —CN, —C(O)NR3R4, —S(O)2R5; C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, wherein the latter three groups are optionally substituted by one or more F;
R2 represents C1-6 alkyl optionally substituted by one or more F;
R3 and R4 each independently represent H or C1-6 alkyl optionally substituted by one or more F;
R5 represents C1-6 alkyl optionally substituted by one or more F;
which process comprises the steps of:
(i) forming a compound of formula II,
wherein R1 and R2 are as defined for a compound of formula I and R6 represents C1-6 alkyl optionally substituted by one or more F, or phenyl optionally substituted by one or more groups selected from halo, methyl and —NO2;
by reacting a compound of formula III
wherein R1 and R2 are as defined for a compound of formula I or II;
with a suitable sulfonating agent in the presence of a suitable base B1
and a suitable solvent S1,
and subsequently
(ii) reacting the compound of formula II, with a compound of formula IV,
wherein M+ represents Li+, Na+, K+ or Cs+
wherein the compound of formula III is provided as a single enantiomer.

### Claim 2 (depends on 1)

The process as claimed in claim 1, wherein the compound of formula II is not isolated from the reaction mixture from step (i) before it is used in step (ii).

### Claim 3 (depends on 1)

The process as claimed in claim 1, wherein S1 is a solvent in which the salt formed between B1 and the leaving group of the sulfonating agent is insoluble.

### Claim 4 (depends on 1)

The process as claimed in claim 1, wherein step (ii) comprises bringing a solution of a compound of formula II in a suitable solvent S1 into association with a solution of a compound of formula IV in a suitable solvent S2.

### Claim 5 (depends on 4)

The process as claimed in claim 4, wherein S2 is a polar aprotic solvent.

### Claim 6 (depends on 4)

The process as claimed in claim 4, wherein S2 is N,N-dimethylformamide.

### Claim 7 (depends on 1)

The process as claimed in claim 1, wherein the process further comprises the step of:
(iii) preparing a compound of formula IV by reacting a compound of formula V
with a suitable base B2 in the presence of a suitable solvent S2,
optionally wherein the solution of a compound of formula IV is obtained from step (iii), after one or more purification steps.

### Claim 8 (depends on 7)

The process as claimed in claim 7, wherein B2 is selected from the group consisting of lithium hydroxide, lithium carbonate, sodium hydroxide, sodium carbonate, potassium hydroxide, potassium carbonate, caesium hydroxide and caesium carbonate.

### Claim 9 (depends on 7)

The process as claimed in claim 7, wherein B2 is sodium hydroxide.

### Claim 10 (depends on 1)

The process as claimed in claim 1, wherein S1 is selected from the group consisting of diethyl ether, methyl tert-butyl ether, 1,2-dimethoxyethane, 1,4-dioxane, tetrahydrofuran and 2-methyltetrahydrofuran.

### Claim 11 (depends on 1)

The process as claimed in claim 1, wherein B1 is an organic amine base.

### Claim 12 (depends on 1)

The process as claimed in claim 1, wherein R1 represents aryl or pyridyl optionally substituted with one or more groups selected from halo, —CN, —SO2Me, or —CONH2.

### Claim 13 (depends on 1)

The process as claimed in claim 1, wherein R2 represents C1-3 alkyl.

### Claim 14 (depends on 1)

The process as claimed in claim 1, wherein the process further comprises the step of:
(ib) removal of the salt formed between B1 and the leaving group of the sulfonating agent from the solution of a compound of formula II in S1 obtained from step (i).

### Claim 15 (depends on 1)

The process as claimed in claim 1, further comprising the step of:
(iv) treating the crude material obtained from step (ii) with a suitable solvent S4 to cause precipitation of the compound of formula I, optionally wherein S4 is acetonitrile.

### Claim 16 (depends on 1)

The process as claimed in claim 1, wherein the sulfonating agent is mesyl chloride or tosyl chloride.

### Claim 17 (depends on 1)

The process as claimed in claim 1, wherein the process is a process for the preparation of a compound of formula Ia, or a salt thereof,
wherein R1 represents aryl or pyridyl optionally substituted with one or more groups selected from halo, —CN, —C(O)NR3R4, —S(O)2R5; C1-6 alkyl, C2-6 alkenyl, C2-6 alkynyl, wherein the latter three groups are optionally substituted by one or more F, and R2 represents C1-6 alkyl optionally substituted by one or more F.

### Claim 18 (depends on 17)

The process as claimed in claim 17, wherein the compound of formula Ia is 6-amino-2-{[(1S)-1-phenylethyl]sulfanyl}pyrimidin-4-ol, or a salt thereof

### Claim 19 (depends on 17)

The process as claimed in claim 17, wherein the compound of formula Ia has a chiral purity of greater than 96%.

### Claim 20 (depends on 1)

The process as claimed in claim 1, wherein S1 is methyl tert-butyl ether.

### Claim 21 (depends on 1)

The process as claimed in claim 1, wherein B1 is triethylamine.

### Claim 22 (depends on 1)

The process as claimed in claim 1, wherein R1 represents phenyl.

### Claim 23 (depends on 1)

A process as claimed in claim 1, wherein R2 represents methyl.
